Juniper Investment Company, LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 15, 2024), Juniper Investment Company, LLC reported 10 stock positions worth $201.0 million. Its top holding was Artivion (AORT) at 22.1% of the portfolio, followed by Bioventus Class A (BVS, 17.7%) and Lincoln Educational Services (LINC, 17.1%). Compared with Q4 2023, it opened 1 new position, sold out of 1, added to 2 and reduced 1. The biggest buy was Allient (ALNT, shares +12%) and the biggest sale Lincoln Educational Services (LINC, shares −16%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001794034
- Portfolio Value
- $201.0M (Q1 2024)
- SEC Filing
- 0001214659-24-009303 ↗ filed May 15, 2024
Holdings Value
Holdings 10 stocks · $201.0M
| AORT Artivion Inc. | 22.09% | 2,098,164 | $44.4M | No change |
| BVS Bioventus Inc. Class A | 17.68% | 6,833,857 | $35.5M | No change |
| LINC Lincoln Educational Services | 17.06% | 3,319,534 | $34.3M | Reduce -16.4% |
| VSEC Vse Corp. | 14.50% | 364,329 | $29.1M | No change |
| ALNT Allient Inc. | 13.47% | 758,652 | $27.1M | Add +12.2% |
| TWIN Twin Disc Inc. | 8.43% | 1,024,954 | $16.9M | No change |
| ALOT Astronova Inc. | 4.75% | 535,203 | $9.5M | No change |
| INTT Intest Corp. | 1.33% | 201,966 | $2.7M | Add +72.9% |
| LYTS Lsi Industries Inc. | 0.48% | 63,874 | $966K | No change |
| XTNT Xtant Medical Holdings Inc. | 0.20% | 348,399 | $408K | New |
Portfolio Sells Q4 2023 → Q1 2024
Portfolio Buys Q4 2023 → Q1 2024
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $377.5M | LINC, ALNT, BVS, AORT, OFIX |
| Q1 2026 | 8 | $313.1M | LINC, BVS, ALNT, OFIX, AORT |
| Q4 2025 | 8 | $290.9M | LINC, AORT, OFIX, BVS, ALNT |
| Q3 2025 | 9 | $261.4M | AORT, LINC, BVS, OFIX, ALNT |
| Q2 2025 | 11 | $242.6M | AORT, LINC, BVS, ALNT, OFIX |
| Q1 2025 | 11 | $221.9M | BVS, AORT, LINC, OFIX, ALNT |
| Q4 2024 | 11 | $253.5M | BVS, AORT, LINC, OFIX, ALNT |
| Q3 2024 | 12 | $239.5M | BVS, AORT, LINC, ALNT, OFIX |
| Q2 2024 | 12 | $208.6M | AORT, LINC, BVS, VSEC, ALNT |
| Q1 2024 | 10 | $201.0M | AORT, BVS, LINC, VSEC, ALNT |